Exelixis EXEL Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's total revenue?
- Exelixis (EXEL) reported total revenue of $610.81M in Q1 2026.
- How has Exelixis's total revenue changed year-over-year?
- Exelixis's total revenue increased by 10.0% year-over-year, from $555.45M to $610.81M.
- What is the long-term trend for Exelixis's total revenue?
- Over 4 years (2021 to 2025), Exelixis's total revenue has grown at a 12.8% compound annual growth rate (CAGR), from $1.43B to $2.32B.
- What does total revenue mean?
- The total amount of money generated from sales before any expenses are deducted.
- How do you interpret total revenue?
- An increase indicates growing market share or successful product adoption, while a decrease may signal competitive pressure or patent expirations.
- How does total revenue compare across companies?
- Standard across all biopharma companies; peers typically report this as Net Sales or Total Revenue.